Future of Launch in an Era of Volatility

Jeff Dill is Group President of Innovation & Growth at Inizio Ignite, where he leads data and AI, sales, and commercial enablement efforts to help clients accelerate growth. With over 20 years of consulting experience, including as former CEO of Vynamic, Jeff has guided global healthcare organizations in strategy, operations, and culture transformation. He is known for his “TACT” approach – Transparency, Awareness, Clarity, and Trust – and for building high-performing, purpose-driven teams.

Ryan Wyrtzen is a Partner on the senior leadership team in Putnam’s Value, Pricing and Access Practice, with over 14 years of experience advising biopharmaceutical and life sciences companies. He specializes in pricing, market access, and product strategy, with deep expertise in vaccines and oncology across global markets. Ryan previously worked at the Massachusetts Health Connector and holds an MBA from Harvard Business School and a BA from Brown University.

Mariah Hanley is a Partner at Putnam, specializing in asset strategy, launch planning, and market access for innovative therapies. Since completing her PhD at Harvard University, she has supported life sciences clients in advancing early-stage portfolio decisions, shaping clinical development strategies, and preparing for successful product launches. Her expertise spans neurology, rare diseases, oncology, and vaccines, with a focus on translating data into actionable insights across global markets.

Mindy McGrath is a Managing Director at Inizio Ignite, Vynamic, specializing in product launch, market access, and commercial strategy for life sciences organizations. She helps translate complex policy and market dynamics into actionable plans, partnering with senior leaders to drive performance. Mindy has experience across multiple therapeutic areas and holds an MBA from Vanderbilt, with prior roles at PwC and Bristol Myers Squibb.

Ryan Anderson is a commercial leader in life sciences with a track record of driving growth across pharma and digital health. As VP of Strategic Accounts, he leads key client partnerships and growth initiatives for global pharma organizations. His expertise spans sales leadership, brand strategy, and market access. Ryan has built high-performing teams, supported product launches, and developed partnership models that enhance patient care, combining deep industry knowledge with strong strategic and launch excellence capabilities.